-
公开(公告)号:US20220111216A1
公开(公告)日:2022-04-14
申请号:US17558832
申请日:2021-12-22
Applicant: Medtronic, Inc.
Inventor: Zhongping Yang , Thomas A. Anderson , Brian P. Colin , William J. Clemens , Subham Ghosh , Jeffrey M. Gillberg , Maurice T. I. Verbeek , Toine Camps , Lilian Kornet , Berthold Stegemann
Abstract: VfA cardiac therapy uses an implantable medical device or system. The implantable medical device includes a tissue-piercing electrode implanted in the basal and/or septal region of the left ventricular myocardium of the patient's heart from the triangle of Koch region of the right atrium through the right atrial endocardium and central fibrous body. The device may include a right atrial electrode, a right atrial motion detector, or both. The device may be implanted completely within the patient's heart or may use one or more leads to implant electrodes in the patient's heart. The device may be used to provide cardiac therapy, including single or multiple chamber pacing, atrioventricular synchronous pacing, asynchronous pacing, triggered pacing, cardiac resynchronization pacing, or tachycardia-related therapy. A separate medical device may be used to provide some functionality for cardiac therapy, such as sensing, pacing, or shock therapy.
-
公开(公告)号:US20220062630A1
公开(公告)日:2022-03-03
申请号:US17450922
申请日:2021-10-14
Applicant: Medtronic, Inc.
Inventor: Zhongping Yang , Becky L. Dolan , Xin Chen , Thomas A. Anderson , Berthold Stegemann , Maurice Verbeek
Abstract: A pacemaker has a housing and a therapy delivery circuit enclosed by the housing for generating pacing pulses for delivery to a patient's heart. An electrically insulative distal member is coupled directly to the housing and at least one non-tissue piercing cathode electrode is coupled directly to the insulative distal member. A tissue piercing electrode extends away from the housing.
-
公开(公告)号:US20210228892A1
公开(公告)日:2021-07-29
申请号:US17157433
申请日:2021-01-25
Applicant: Medtronic, Inc.
Inventor: Lilian Kornet , Richard Cornelussen , Berthold Stegemann
Abstract: Devices and methods are described herein for treating cardiac conditions using electrical stimulation delivered to and sensing nerve activity from one or both of the AV node and nerve tissue innervating the AV node using one or more neural electrodes positioned in a location within the triangle of Koch of the right atrium.
-
公开(公告)号:US20200230415A1
公开(公告)日:2020-07-23
申请号:US16840083
申请日:2020-04-03
Applicant: Medtronic, Inc.
Inventor: Zhongping Yang , Thomas A. Anderson , Brian P. Colin , William J. Clemens , Subham Ghosh , Jeffrey M. Gillberg , Maurice T.I. Verbeek , Toine Camps , Lilian Kornet , Berthold Stegemann , Jean Rutten
Abstract: VfA cardiac therapy uses an implantable medical device or system. The implantable medical device includes a tissue-piercing electrode implanted in the basal and/or septal region of the left ventricular myocardium of the patient's heart from the triangle of Koch region of the right atrium through the right atrial endocardium and central fibrous body. The device may include a right atrial electrode, a right atrial motion detector, or both. The device may be implanted completely within the patient's heart or may use one or more leads to implant electrodes in the patient's heart. The device may be used to provide cardiac therapy, including single or multiple chamber pacing, atrioventricular synchronous pacing, asynchronous pacing, triggered pacing, cardiac resynchronization pacing, or tachycardia-related therapy. A separate medical device may be used to provide some functionality for cardiac therapy, such as sensing, pacing, or shock therapy.
-
公开(公告)号:US20190290910A1
公开(公告)日:2019-09-26
申请号:US16361970
申请日:2019-03-22
Applicant: Medtronic, Inc.
Inventor: Zhongping Yang , Thomas A. Anderson , Brian P. Colin , William J. Clemens , Subham Ghosh , Jeffrey M. Gillberg , Maurice T. I. Verbeek , Toine Camps , Lilian Kornet , Berthold Stegemann , Jean Rutten
Abstract: VfA cardiac therapy uses an implantable medical device or system. The implantable medical device includes a tissue-piercing electrode implanted in the basal and/or septal region of the left ventricular myocardium of the patient's heart from the triangle of Koch region of the right atrium through the right atrial endocardium and central fibrous body. The device may include a right atrial electrode, a right atrial motion detector, or both. The device may be implanted completely within the patient's heart or may use one or more leads to implant electrodes in the patient's heart. The device may be used to provide cardiac therapy, including single or multiple chamber pacing, atrioventricular synchronous pacing, asynchronous pacing, triggered pacing, cardiac resynchronization pacing, or tachycardia-related therapy. A separate medical device may be used to provide some functionality for cardiac therapy, such as sensing, pacing, or shock therapy.
-
公开(公告)号:US20190209846A1
公开(公告)日:2019-07-11
申请号:US15928714
申请日:2018-03-22
Applicant: Medtronic, Inc.
Inventor: Robert W. Stadler , Richard Cornelussen , Berthold Stegemann
CPC classification number: A61N1/3702 , A61B5/0456 , A61N1/371 , A61N1/3937
Abstract: In some examples, a system can be used for delivering cardiac resynchronization therapy (CRT). The system may include a pacing device configured to be implanted within a patient. The pacing device can include a plurality of electrodes, signal generation circuitry configured to deliver ventricular pacing via the plurality of electrodes, and a sensor configured to produce a signal that indicates mechanical activity of the heart. Processing circuitry can be configured to identify one or more features of a cardiac contraction within the signal, and determine whether the contraction was a fusion beat based on the one or more features.
-
公开(公告)号:US09233251B2
公开(公告)日:2016-01-12
申请号:US14157161
申请日:2014-01-16
Applicant: Medtronic, Inc.
Inventor: Vinayakrishnan Rajan , Berthold Stegemann
CPC classification number: A61N1/3682 , A61N1/368 , A61N1/3684
Abstract: A medical device performs a method for controlling a cardiac pacing therapy. The device determines an inter-atrial conduction time (IACT) and compares the IACT to a threshold. A controller included in the device sets a pacing interval for controlling delivery of pacing pulses to a ventricle to a first ventricular pacing interval that expires after the IACT in response to the IACT being less than the threshold and sets the pacing interval to a second ventricular pacing interval that expires before the IACT in response to the IACT being greater than the threshold.
Abstract translation: 医疗装置执行用于控制心脏起搏治疗的方法。 该装置确定心房间传导时间(IACT)并将IACT与阈值进行比较。 包括在装置中的控制器设置起搏间隔,用于控制向心室递送起搏脉冲到响应于IACT小于阈值的IACT之后到期的第一心室起搏间隔,并将起搏间隔设定为第二心室起搏 响应于IACT大于阈值在IACT之前到期的间隔。
-
公开(公告)号:US12226644B2
公开(公告)日:2025-02-18
申请号:US17661649
申请日:2022-05-02
Applicant: Medtronic, Inc.
Inventor: Stefan G. Kracker , Lilian Kornet , Michelle M. Galarneau , Matthew D. Bonner , Johan Maas , Berthold Stegemann , Paulus C. van Venrooij , Vasiliki Spyropoulou , Victor Peter Jozef Duijsens , Markus J. C. Lazeroms
Abstract: An example medical device includes a plurality of electrodes, therapy delivery circuitry, and processing circuitry configured to control the therapy delivery circuitry to deliver electrical stimulation to an intercostal nerve of a patient via at least two of the plurality of electrodes, wherein the electrical stimulation is delivered with stimulation parameters configured to suppress ventricular tachyarrhythmia of the patient, wherein the stimulation parameters comprise a stimulation frequency less than or equal to 40 hertz (Hz).
-
公开(公告)号:US20240359018A1
公开(公告)日:2024-10-31
申请号:US18765758
申请日:2024-07-08
Applicant: Medtronic, Inc.
Inventor: Robert W. Stadler , Richard Cornelussen , Berthold Stegemann
CPC classification number: A61N1/36578 , A61B5/4836 , A61B5/686 , A61N1/3621 , A61N1/3624 , A61N1/3627 , A61N1/36507 , A61N1/3987 , A61B5/1102 , A61B5/35 , A61N1/3756 , A61N1/39622
Abstract: In some examples, a system can be used for delivering cardiac resynchronization therapy (CRT). The system may include a pacing device configured to be implanted within a patient. The pacing device can include a plurality of electrodes, signal generation circuitry configured to deliver ventricular pacing via the plurality of electrodes, and a sensor configured to produce a signal that indicates mechanical activity of the heart. Processing circuitry can be configured to identify one or more features of a cardiac contraction within the signal, and determine whether the contraction was a fusion beat based on the one or more features.
-
公开(公告)号:US11911623B2
公开(公告)日:2024-02-27
申请号:US16290112
申请日:2019-03-01
Applicant: Medtronic, Inc.
Inventor: Vicki L. Bjorklund , Xin Chen , William J. Clemens , Lilian Kornet , Jean Rutten , Berthold Stegemann , Zhongping Yang
CPC classification number: A61N1/36843 , A61B5/287 , A61B90/39 , A61N1/059 , A61N1/0573 , A61N1/0592 , A61N1/37512 , A61B2090/3966 , A61B2090/3987 , A61N1/368 , A61N1/3627
Abstract: A method, system and device for implanting an electrode assembly of an implantable medical device in a patient's heart. Positioning one or more radiopaque markers in a coronary sinus of the patient's heart. Positioning, by using the one or more positioned radiopaque markers as a fluoroscopic visual reference, a distal tip of a delivery catheter within a right atrium of the patient's heart so that a distal opening of a lumen of the catheter is against a septal wall of the heart at a location between the ostium of the coronary sinus and the A-V nodal area of the right atrium, and so that the tip of the catheter is generally directed toward a left ventricle of the patient's heart. Advancing the electrode assembly through the lumen of the catheter and into the septal wall.
-
-
-
-
-
-
-
-
-